COMMUNIQUÉS West-GlobeNewswire

Ultragenyx Reports First Quarter 2018 Financial Results and Corporate Update
07/05/2018
NOVATO, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today reported [...]
Ascendis Pharma A/S Announces Poster Presentation on TransCon PTH Phase 1 Trial at the European Congress of Endocrinology
07/05/2018
COPENHAGEN, Denmark, May 07, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND ), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs, today [...]
Fulgent Genetics Reports First Quarter 2018 Financial Results
07/05/2018
First Quarter 2018 Results : Revenue of $4.7 million, up 9% sequentially Billable tests delivered grew 10% sequentially to 4,621 GAAP loss of $1.9 million, or $0.11 per share Non-GAAP loss of $1.2 million, or $0.06 per [...]
Assembly Biosciences Announces First Quarter 2018 Financial Results
07/05/2018
INDIANAPOLIS and SAN FRANCISCO, May 07, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB ), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of [...]
GBT Reports Recent Business Progress and First Quarter 2018 Financial Results
07/05/2018
SOUTH SAN FRANCISCO, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today reported recent business progress and financial results for the first quarter ended March 31, 2018 [...]
AxoGen Announces Proposed Public Offering of Common Stock
07/05/2018
ALACHUA, Fla., May 07, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, announced today that it has commenced an [...]
Inspire Medical Systems, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
07/05/2018
MINNEAPOLIS, May 07, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP ) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
MacroGenics Provides Update on Corporate Progress and 1st Quarter 2018 Financial Results
07/05/2018
ROCKVILLE, Md., May 07, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX ), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Integra LifeSciences Announces Amendment and Extension of Credit Facility
07/05/2018
PLAINSBORO, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART ), a leading global medical technology company, today announced that it has amended and extended its credit [...]
Sientra, Inc. Announces Closing of $115 Million Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option
07/05/2018
SANTA BARBARA, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN ) (“Sientra” or the “Company”), a medical aesthetics company, today announced the closing of its previously announced underwritten [...]
Mersana Therapeutics to Host Conference Call Announcing First Quarter 2018 Financial Results and Business Updates
07/05/2018
CAMBRIDGE, Mass., May 07, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN ), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]
scPharmaceuticals Inc. Reports First Quarter 2018 Financial Results and Provides Business Update
07/05/2018
Company’s lead investigational product, FUROSCIX ® , has a PDUFA date of June 23, 2018 Company has initiated staged commercialization activities for FUROSCIX BURLINGTON, Mass., May 07, 2018 (GLOBE NEWSWIRE) -- [...]
CytomX to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
07/05/2018
SOUTH SAN FRANCISCO, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX ), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
CityMD Earns National Recognition for Connected Care
07/05/2018
NCQA Patient-Centered Connected Care™ Recognizing Trusted Partners for Patient Care WASHINGTON, DC, May 07, 2018 (GLOBE NEWSWIRE) -- The National Committee for Quality Assurance (NCQA) today announced that CityMD, the [...]
FDA & Industry Veteran Brian E. Harvey, MD, PhD, Joins Thetis Pharmaceuticals as Senior Medical Director
07/05/2018
Former FDA GI Division Director and V.P. of U.S. Regulatory Strategy at Pfizer to Guide Clinical and Regulatory Development of Thetis IBD Programs BRANFORD, Conn., May 07, 2018 (GLOBE NEWSWIRE) -- Thetis Pharmaceuticals [...]
VALNEVA : Déclaration d'actions et de droits de vote - AVRIL 2018
07/05/2018
VALNEVA Déclaration d'actions et de droits de vote - AVRIL 2018 Dénomination sociale : VALNEVA Adresse du siège social : World Trade Center Lyon - Tour Oxygène, 10-12 Boulevard Marius Vivier Merle, 69003 Lyon Marché [...]
Ossur Hf : Transactions in relation to share buyback program
07/05/2018
Announcement no. 34/2018 Reykjavik, 7 May 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]
ImmuCell to Announce Financial Results for First Quarter of 2018
07/05/2018
Conference Call Scheduled for Monday, May 14, 2018 at 4:30 PM ET PORTLAND, Maine, May 07, 2018 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC ) (“ImmuCell” or the “Company”), a growing animal health company that [...]
On “Grindeks” audited results in 2017
07/05/2018
Turnover of “Grindeks” reaches 132.4 million euro in 2017; profit – 10.0 million euro JSC “Grindeks” informs that submission of audited consolidated financial statements of 2017 of JSC “Grindeks” was delayed due to the [...]

Pages